Tyra Biosciences: Pro-forma Cash Position of About $403.5 M Expected to Support Clinical and Operational Milestones Through at Least 2026 >TYRA
Tyra Biosciences: Pro-forma Cash Position of About $403.5 M Expected to Support Clinical and Operational Milestones Through at Least 2026 >TYRA
Tyra Biosciences:预计约4.035亿美元的预计现金状况将在至少2026年之前支持临床和运营里程碑 >TYRA
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册